Table 1.
Basic Clinicopathological Characteristics in Locally Advanced Intrahepatic Cholangiocarcinoma
| Variables | Total (n=159, %) | Variables | Total (n=159, %) |
|---|---|---|---|
| Age, (years) | 55.3±10.6 | Surgical Margin | |
| Gender | >1cm | 93 (58.5) | |
| Female | 60 (37.7) | ≤ 1cm | 66 (41.5) |
| Male | 99 (62.3) | RLNM | |
| Liver Cirrhosis | Negative | 120 (75.5) | |
| No | 23 (14.5) | Positive | 39 (24.5) |
| Yes | 74 (46.5) | Adjuvant postoperative therapy | |
| Unknown | 62 (39) | No | 94 (59.1) |
| Tumor Diameter, (cm) | 6.6 ± 2.8 | Yes | 65 (40.9) |
| Tumor number | CEA, (U/mL) | 15.7 ± 39.2 | |
| Single | 103 (64.8) | CA19-9, (U/mL) | 927.2 ± 2835.4 |
| Multiple | 56 (35.2) | pCEA, (U/mL) | 3.9 ± 6.8 |
| Grade | pCA19-9, (U/mL) | 87.8 ± 321.2 | |
| Well/Moderate | 51 (32.1) | SII | 650.5 ± 458.8 |
| Poor/Undifferentiated | 108 (67.9) | AISI | 364.9 ± 410.3 |
| MVI | SIRI | 11 ± 9.5 | |
| Absent | 116 (73) | GPR | 0.6± 0.8 |
| Present | 43 (27) | PNI | 52.9 ± 10.1 |
| Resection Scope | ALI | 50.9 ± 80.2 | |
| Minor | 77 (48.4) | ||
| Major | 82 (51.6) |
Abbreviations: MVI, microvascular invasion; RLNM, regional lymph node metastasis; CEA, carcino-embryonic antigen; CA19-9, carbohydrate antigen 19-9; pCEA, postoperative CEA; pCA19-9, postoperative CA19-9; SII, systemic immune- inflammation index; AISI, aggregate systemic inflammation index; SIRI, systemic inflammation response index; GPR, gamma-glutamyl-transpeptidase to platelet ratio; PNI, prognostic nutrition index; ALI, advanced lung cancer index.